Meyka Pro banner
Scilex Holding Company

Scilex Holding Company (SCLX) Stock Overview

Explore Scilex Holding Company’s financial performance, market position, analyst ratings, and future outlook.

SCLXNASDAQ
HealthcareDrug Manufacturers - General
$6.69
$0.26(3.74%)
U.S. Market opens in 1h 34m

Scilex Holding Company (SCLX)

Meyka AI Score

Z

Key Financials

Market Cap56.8M
P/E Ratio-0.18
EPS (TTM)$-38.95
ROE1.90%
Fundamental Analysis

AI Price Forecasts

1 Month$11.20
3 Months$9.96
1 Year Target$14.31

SCLX Stock Analysis & Investment Overview (NASDAQ)

Our AI-powered analysis of Scilex Holding Company (NASDAQ: SCLX) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B, Scilex Holding Company's NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of SCLX on the NASDAQ shows an RSI of 44.11, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $14.31 for the NASDAQ listing.

Key metrics behind Scilex Holding Company's NASDAQ-traded stock include a P/E ratio of -0.18 and a market capitalization of 56.8M. Combined with our AI analysis, these give both institutional and retail investors a clear view of SCLX on the NASDAQ.

Price Performance (NASDAQ: SCLX)

1-Day Change
-3.74%
5-Day Change
2.14%
1-Month Change
-29.43%
3-Month Change
-14.45%
6-Month Change
-25.00%
Year-to-Date (YTD) Change
-45.16%
1-Year Change
-57.71%
3-Year Change
-95.57%
5-Year Change
-98.08%
All-Time (Max) Change
-98.06%

Contact Information

650-516-4310
960 San Antonio Road, Palo Alto, CA, 94303

Company Facts

340 Employees
IPO DateMar 5, 2021
CountryUS
Actively Trading

Frequently Asked Questions